Da Hee Han, PharmD

All articles by Da Hee Han, PharmD

FDA to Review Selective Adenosine Receptor Antagonist NDA for Parkinson Disease

Kyowa Hakko Kirin announced that the Food and Drug Administration (FDA) has accepted the resubmitted New Drug Application (NDA) for istradefylline (KW-6002) for use as adjunctive treatment to levodopa/carbidopa in adults with Parkinson disease (PD) experiencing OFF episodes. The NDA submission was rejected in 2008 due to concerns over efficacy findings. Istradefylline is an oral…

Next post in Pediatric Neurology